MODIFICATION
A -- Synthesis and Distribution of Drugs of Abuse and Related Compounds
- Notice Date
- 2/11/2022 5:32:51 AM
- Notice Type
- Solicitation
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N95022R00016
- Response Due
- 3/11/2022 12:00:00 PM
- Archive Date
- 03/26/2022
- Point of Contact
- Shaun Rostad, Phone: 301-443-6677, K.J. Shaikh, Phone: 410-443-6677
- E-Mail Address
-
shaun.rostad@nih.gov, kj.shaikh@nih.gov
(shaun.rostad@nih.gov, kj.shaikh@nih.gov)
- Description
- Please refer to Attachment below containing the RFP Cover Letter, RFP and all accompanying RFP Attachments for complete details and submission instructions. The National Institute on Drug Abuse (NIDA) plans to solicit proposals under full and open competition procedures from qualified organizations having the capability to synthesize and distribute drugs of abuse and related compounds. The NIDA Drug Supply Program has played an important role in promoting and supporting the drug abuse research by providing to the drug abuse research community a wide variety of authentic and pure controlled drugs and other chemical compounds (both unlabeled and labeled with deuterium, tritium, carbon -14, and iodine-125 isotopes) for basic research. These drugs and research chemicals are either: very expensive to buy, or are controlled by the U.S. Drug Enforcement Administration (DEA) or commercially unavailable. They are generally procured by chemical synthesis through contract mechanism. In order to continue to supply authentic and pure drugs and research chemicals, NIDA intends to maintain the drug supply inventory, periodically check chemical purity and supply to research investigators according to the NIDA drug supply guidelines. Specifically, NIDA plans to continue: (1) to acquire, synthesize and maintain several radio and deuterium labeled and unlabeled drugs of abuse and other chemical substances in its drug supply inventory and distribute them to research investigators upon approval; (2) to check their stability and purity periodically and produce updated chemical data sheets; (3) to replenish existing drug supply inventory with depleted drugs and research compounds; (4) to identify, acquire, and update the drug supply inventory with newly discovered chemical compounds useful for drug abuse research; and (5) to use, maintain, and update the NIDA drug supply data base, known as Drug Inventory Supply Control System (DISCS). This is a follow-on procurement to Contract Number HHSN271201800011I titled �Synthesis and Distribution of Drugs of Abuse and Related Compounds.� �NIDA anticipates the award of a single indefinite delivery, indefinitely quantity (IDIQ) task order contract for a period of performance of five years. NIDA may award cost reimbursement task orders under this contract.� NIDA anticipates that at least one task order will be awarded with the contract. MANDATORY CRITERIA In order to handle substances under the Controlled Substances Act of 1970, it is mandatory that offerors possess a Drug Enforcement Administration (DEA) Registration for Chemical Analysis or Research Registration for Schedules II to V and demonstrate the capability to obtain a DEA registration for Schedule I controlled substances. ADDITIONAL INFORMATION The attached RFP No. 75N95022R00016 has a proposal DUE DATE of Mach 11th, 2022 at 3:00 p.m. You can access the RFP through the link below. NIDA will consider proposals submitted by any responsible offeror. This advertisement does not commit the Government to award a contract.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/8b85d6a95d9b41bda687ada3318718b3/view)
- Record
- SN06240010-F 20220213/220211230102 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |